INKT icon

MiNK Therapeutics
INKT

Overview Fund Activity

25 hedge funds and large institutions have $1.76M invested in MiNK Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
+4
Holders Change %
+19.05%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
1
Bridgeway Capital Management
Texas
$80K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$76K
3
BlackRock
3
BlackRock
New York
$40K
4
State Street
4
State Street
Massachusetts
$38K
5
UBS Group
5
UBS Group
Switzerland
$12K

Top Sellers

1
RI
1
RTW Investments
New York
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
GTCM
3
Gyon Technologies Capital Management
New Jersey
$0
4
Invesco
4
Invesco
Georgia
$0
5
SI
5
Sofinnova Investments
California
$745K
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$0 124 -361 -74%
AIP
27
Ameritas Investment Partners
Nebraska
$0 150 – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
Deutsche Bank
29
Deutsche Bank
Germany
$0 12 +12 New
Fidelity Investments
30
Fidelity Investments
Massachusetts
$0 157 +157 New
1
2